US OptionsDetailed Quotes

CMRX241115C1000

Watchlist

0.05
+0.02+66.67%

15min DelayClose Oct 31 16:00 ET

0.09High0.05Low

Chimerix Stock Discussion

101674396

Oct 28 11:57

$Chimerix (CMRX.US)$ …why high peak?

Goldman Sachs

Aug 20 15:05

Tonix initiates Phase II trial for emergency cocaine intoxication treatment
$Tonix Pharmaceuticals (TNXP.US)$

101674396

Aug 20 03:47

$Chimerix (CMRX.US)$ .. supposed be rise…but drop !!!!

Analysts Notebook

Aug 19 08:18

Columns Monkeypox Outbreak Drove Surge in These Company Shares

As health authorities worldwide work to contain the monkeypox outbreak, investors quickly buy shares in companies that might profit from efforts to control the disease.
Investors are buying up shares of vaccine producers, antiviral drug makers, and protective equipment companies, hoping to profit as they did during the coronavirus pandemic.
Bavarian Nordic, the only producer approved of the pox vaccine, saw its shares jump 16.5% on the day in...

Stock_Drift

Aug 18 17:37

8/19/24 🦍’s 👀’s on 🚨🚨🚨🚨

$Virax Biolabs (VRAX.US)$ $Airship AI (AISP.US)$ $Personalis (PSNL.US)$ $Emergent BioSolutions (EBS.US)$ $Chimerix (CMRX.US)$ $Tonix Pharmaceuticals (TNXP.US)$
📊⚡️📊

Trytosaveabit

May 9 04:33

On watch! Note upcoming data!

$Chimerix (CMRX.US)$ ONC206 is a second generation ClpP agonist and DRD2 antagonist that has demonstrated monotherapy anti-cancer activity in pre-clinical models in primary CNS tumors and solid tumors outside of the CNS.
Phase I dose escalation trials continue at the National Institutes of Health (NIH) and the Pacific Pediatric Neuro-Oncology Consortium (PNOC) in adult and pediatric CNS tumor patients, respectively. The dose escalation trials are currently dosing at a...

102179621

May 2 08:35

钱途看好！大胆买进

$Chimerix (CMRX.US)$ Strong Buy Rating for Chimerix on Robust Financials and Promising Drug Pipeline

Moomoo AI

Dec 29, 2023 06:01

Mike Andriole, CEO of Chimerix, welcomes Lisa Decker for her scientific expertise, oncology drug development and business development experience. He appreciates her as an asset to Chimerix as the company advances its pipeline towards commercialization.

Press Release: Chimerix Appoints Lisa Decker to Board of Directors

Moomoo AI

Dec 4, 2023 06:08

Chimerix's CEO is confident in Michelle's potential to push the company into its next growth phase. Michelle is keen on opportunities for Chimerix's growth, particularly for the imipridone pipeline, and aims to help turn Chimerix into a top oncology firm.

Press Release: Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

Moomoo AI

Nov 16, 2023 06:09

The inclusion of Thomas Riga in the Chimerix leadership team is expected to boost the company’s operations given his extensive experience in oncology commercialization and corporate business development, especially as the company gears towards commercializing its clinical-stage development program, ONC201.

Press Release: Chimerix Strengthens Executive Leadership Team With Appointment of Thomas Riga as Chief Operating and Commercial Officer

No comment yet